| Supplementary Information: | |||||||||||||||
| Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Percentage | |||||||||||||||
| (Unaudited) | |||||||||||||||
| Three months ended | Nine months ended | ||||||||||||||
| (Expressed in thousands of U.S. dollars) |
September 27,
2020 |
September 29,
2019 |
September 27,
2020 |
September 29,
2019 | |||||||||||
| Net income (loss) | $ | 1,243 | $ | (5,734 | ) | $ | 2,973 | $ | (6,991 | ) | |||||
| Add (deduct): | |||||||||||||||
| Depreciation of property, plant and equipment | 1,545 | 1,649 | 4,767 | 4,902 | |||||||||||
| Amortization of Intangible assets | 354 | 1,844 | 2,718 | 5,532 | |||||||||||
| Interest | 1,941 | 2,679 | 6,021 | 8,349 | |||||||||||
| Income tax expense (recovery) | 204 | (184 | ) | 857 | 606 | ||||||||||
| EBITDA | $ | 5,287 | $ | 254 | $ | 17,336 | $ | 12,398 | |||||||
| Add (deduct): | |||||||||||||||
| Restructuring charges | 871 | 6,454 | 525 | 8,624 | |||||||||||
| Stock compensation expense | 158 | 353 | 475 | 538 | |||||||||||
| Fair value adjustment of warrant liability | 133 | (858 | ) | 15 | (919 | ) | |||||||||
| Fair value adjustment of contingent consideration | - | - | - | (3,050 | ) | ||||||||||
| Merger and acquisitions related expenses | - | 68 | - | 232 | |||||||||||
| COVID-19 related expenses | 1,348 | - | 2,533 | - | |||||||||||
| Unrealized foreign exchange gain | |||||||||||||||
| on unsettled forward exchange contracts | (261 | ) | - | (720 | ) | - | |||||||||
| Adjusted EBITDA | $ | 7,536 | $ | 6,271 | $ | 20,164 | $ | 17,823 | |||||||
| Adjusted EBITDA Percentage | 7.6 | % | 7.1 | % | 7.1 | % | 6.3 | % | |||||||
